Clinical Trial Update: 9-valent HPV Vaccine in Postpartum Women [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for a 9-valent HPV vaccine in postpartum women; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection
• Human Papillomavirus-related Disease

Drugs mentioned

• 9-valent HPV vaccine

Snippet

Sponsor: Augusta University | Conditions: Human Papilloma Virus | Phase 4 | Status: UNKNOWN